RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

Monevis vs FundedFirm

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

MNVS

Monevis

EST. 2023

FNFM

FundedFirm

MONEVIS

METRIC

FUNDEDFIRM

68/100BETTER

TRUST SCORE

—0/100

0/5TIE

RATING

TIE0/5

85%—

PROFIT SPLIT

BETTER100%

$400,000BETTER

MAX FUNDING

—$100,000

$49BETTER

MIN COST

—$549

7d—

PAYOUT DAYS

BETTER1d

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

MONEVIS DETAILS

STEPS: 2-phase
DRAWDOWN: Fixed
MARKETS: Forex, Indices, Commodities, Metals
PLATFORMS: MT4, MT5
TYPES: forex

FUNDEDFIRM DETAILS

STEPS: 1-phase
DRAWDOWN: Fixed
MARKETS: Forex
PLATFORMS: MT5

Monevis PROS

+Profit split of 85% is above the industry average of 84.7%, giving traders a slightly better earnings share.
+Min challenge cost of $49 is well below the industry average of $186.7, making entry highly affordable.
+Weekend holding, news trading, and EA/automated trading are all permitted, supporting diverse trading approaches.
+On-demand payouts provide traders with maximum flexibility in withdrawing earned profits.

Monevis CONS

−Max funding of $400,000 is well below the industry average of $839,272.7, limiting overall earning potential.
−Overall drawdown of 8% slightly exceeds the industry average of 7.9%, offering marginally less buffer.
−Founded in 2023, Monevis has a limited track record, which may concern traders prioritising firm stability.

FundedFirm PROS

+100% profit split is exceptionally above the industry average of 84.7%
+Days to first payout of 1 is significantly faster than the industry average of 6.5 days
+Single-step evaluation is below the industry average of 1.6 steps to funded
+Fee refund is available, reducing the net cost of the evaluation

FundedFirm CONS

−Max funding of $100,000 is well below the industry average of $839,272.70
−Min challenge cost of $549 is significantly above the industry average of $186.7
−Profit target of 10% is above the industry average of 7.9%, making evaluation harder to pass

PROPDNA VERDICT

Monevis

Higher trust score (68/100). Slower payouts at 7d. 85% profit split.

START WITH MNVS